Page 103 - 《中国药房》2023年23期
P. 103

临床特异性的,且患者的肝功能是正常的,往往容易漏                                2014,13(7):853-857.
                                                    [16]
          诊、误诊,所以及时发现并诊断VHE是至关重要的 。                          [ 7 ]  陈琪莹,李毅敏,陈文发 . 基于 FAERS 对沙库巴曲缬沙
          3.2.2 VPA潜在AE                                           坦不良反应的分析研究[J]. 中国医院药学杂志,2021,41
              本研究挖掘到 VPA 药品说明书未提及且为阳性信                           (3):264-268.
                                                                  CHEN Q Y,LI Y M,CHEN W F. Analytical study of ad‐
          号的AE共46个,累及2个SOC。其中,值得注意的是视
                                                                  verse reactions of sacubitril/valsartan based on FAERS[J].
          觉损害、斜视、散光、近视等眼部 AE,报告频次均超过
                                                                  Chin J Hosp Pharm,2021,41(3):264-268.
          100且2种算法均呈阳性。一项纳入了86例患者的观察
                                                             [ 8 ]  LANSNER A,HOLST A. A higher order Bayesian neural
          性病例对照研究结果显示,VPA对视网膜神经纤维层和
                                                                  network with spiking units[J]. Int J Neural Syst,1996,7
          黄斑厚度会产生不良影响 。Gogri等 报告了1例VPA                           (2):115-128.
                               [17]
                                          [18]
          诱发双侧白内障的病例。这些研究均提示,VPA可能具                          [ 9 ]  GALLAGHER R M,BIRD K A,MASON J R,et al. Ad‐
          有潜在的眼毒性,但仍需要更大样本临床研究予以证实。                               verse drug reactions causing admission to a paediatric hos‐
              本研究还发现,VPA 有导致感染的风险,且主要发                            pital:a pilot study[J]. J Clin Pharm Ther,2011,36(2):
          生 在 耳 部 ,包 括 耳 部 感 染(175 例 次 ,ROR025=3.77,              194-199.
          IC025=1.87)、中 耳 炎(70 例 次 ,ROR025=11.51,IC025=      [10]  郭雪芬 . 丙戊酸钠的血药浓度监测和合理用药分析[J].
          3.22)等,但目前尚没有队列研究等临床数据能够直接证                             世界最新医学信息文摘,2018,18(26):101-102.
          实,后续仍需要更多的临床试验进行验证。                                     GUO X F. Monitoring of blood concentration of sodium
              综上所述,本研究基于FAERS数据库,采用ROR法                           valproate  and  analysis  of  rational  drug  use[J].  World
          和 BCPNN 法对 VPA 的 AE 信号进行挖掘,相对全面地                        Latest Med Inf,2018,18(26):101-102.
                                                             [11]  WANG  Y,HU  W  Q,LI  Z  P.  Influence  of  age  and  co-
          呈现了 VPA 的安全信号谱。VPA 作为一线广谱抗癫痫
                                                                  medication  on  the  concentration  and  efficacy  of  valproic
          治疗药物,在临床应用中,除了要关注药品说明书中常
                                                                  acid  in  Chinese  epilepsy  children[J].  Pak  J  Pharm  Sci,
          见的AE外,还需要关注眼毒性及感染风险。                                    2020,33(2):537-542.
          参考文献                                               [12]  MURALIDHARAN  A,RAHMAN  J,BANERJEE  D,
          [ 1 ]  吴冬燕,朱国行. 抗癫痫药物的分类、作用机制与不良反                       et al. Parkinsonism:a rare adverse effect of valproic acid
              应[J]. 上海医药,2015,36(9):3-7.                          [J]. Cureus,2020,12(6):e8782.
              WU D Y,ZHU G X. Classification,mechanism and ad‐  [13]  KIM D W,KIM W,LEE C H,et al. Thrombocytopenia
              verse  effects  of  antiepileptic  drugs[J].  Shanghai  Med   during intravenous valproic acid therapy in the neurologi‐
              Pharm J,2015,36(9):3-7.                             cal intensive care unit[J]. J Clin Pharm Ther,2020,45(5):
          [ 2 ]  王绚,张永,张媛媛. 基于AERS的丙戊酸不良反应信号                      1014-1020.
              挖掘与数据分析[J]. 中国医院药学杂志,2020,40(1):               [14]  WU  J  H,LI  J  Y,JING  W,et  al.  Valproic  acid-induced
              71-77.                                              encephalopathy:a review of clinical features,risk factors,
              WANG  X,ZHANG Y,ZHANG Y Y.  Data  analysis  and     diagnosis,and  treatment[J].  Epilepsy  Behav,2021,120:
              signal excavation of valproic acid induced ADR based on   107967.
              the AERS[J]. Chin J Hosp Pharm,2020,40(1):71-77.  [15]  仇东婷,张艳娟 . 丙戊酸钠相关性高血氨脑病 1 例及药
          [ 3 ]  CANTELMI T,LEPORE E,UNFER V R,et al. Safety of   学监护讨论[J]. 中国药物滥用防治杂志,2023,29(3):
              inositol supplementation in patients taking lithium or val‐  423-426.
              proic acid:a pilot clinical study[J]. Eur Rev Med Pharma‐  QIU D T,ZHANG Y J. Clinical pharmacists participate in
              col Sci,2022,26(19):7269-7276.                      the  pharmaceutical  care  of  a  case  of  sodium  valproate-
          [ 4 ]  侯永芳,王玲,郭秀花,等. 信号检测在药品不良反应监                       related hyperammonemia encephalopathy[J]. Chin J Drug
              测系统中的应用[J]. 中国药物警戒,2012,9(9):539-541.               Abuse Prev Treat,2023,29(3):423-426.
              HOU Y F,WANG L,GUO X H,et al. Signal detection in   [16]  WONG  Y  J,FAN  J  L,WAN  A,et  al.  Valproic  acid-
              the software for adverse drug reaction monitoring[J]. Chin   associated  hyperammonemia:a  systematic  review[J].  J
              J Pharmacovigil,2012,9(9):539-541.                  Clin Psychopharmacol,2023,43(3):283-294.
          [ 5 ]  ANG  P  S,CHEN  Z  J,CHAN  C  L,et  al.  Data  mining   [17]  XIONG W X,LU L,ZHANG Y Y,et al. Attenuation of
              spontaneous adverse drug event reports for safety signals   retinal nerve fibre layer in people with epilepsy receiving
              in  Singapore:a  comparison  of  three  different  dispropor‐  valproate[J]. Epilepsy Res,2019,154:144-148.
              tionality measures[J]. Expert Opin Drug Saf,2016,15(5):  [18]  GOGRI  P  Y,BHALERAO  S,VUYYURU  S.  Sodium
              583-590.                                            valproate-induced  cataract[J].  BMJ  Case  Rep,2021,14
          [ 6 ]  HOU Y F,YE X F,WU G Z,et al. A comparison of dis‐  (1):e240997.
              proportionality analysis methods in national adverse drug     (收稿日期:2023-04-21  修回日期:2023-10-11)
              reaction  databases  of  China[J].  Expert  Opin  Drug  Saf,                        (编辑:刘明伟)


          中国药房  2023年第34卷第23期                                              China Pharmacy  2023 Vol. 34  No. 23    · 2909 ·
   98   99   100   101   102   103   104   105   106   107   108